Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ezio Carboni"'
Autor:
Ezio Carboni, Anna R. Carta
Publikováno v:
Journal of Integrative Neuroscience, Vol 21, Iss 5, p 144 (2022)
Major depressive disorder is one of the primary causes of disability and disease worldwide. The therapy of depression is prevalently based on monoamine reuptake blockers; consequently, investigations aimed to clarify the aetiology of depression have
Externí odkaz:
https://doaj.org/article/f98ca508ddf64749b032654e64830f77
Autor:
Maria Francesca Palmas, Michela Etzi, Augusta Pisanu, Chiara Camoglio, Claudia Sagheddu, Michele Santoni, Maria Francesca Manchinu, Mauro Pala, Giuliana Fusco, Alfonso De Simone, Luca Picci, Giovanna Mulas, Saturnino Spiga, Maria Scherma, Paola Fadda, Marco Pistis, Nicola Simola, Ezio Carboni, Anna R. Carta
Publikováno v:
Cells, Vol 11, Iss 17, p 2628 (2022)
Parkinson’s disease (PD) is a complex pathology causing a plethora of non-motor symptoms besides classical motor impairments, including cognitive disturbances. Recent studies in the PD human brain have reported microgliosis in limbic and neocortica
Externí odkaz:
https://doaj.org/article/3eedc67be715406cbd276027691c9ffd
Publikováno v:
Frontiers in Neuroscience, Vol 15 (2021)
Repurposing ketamine in the therapy of depression could well represent a breakthrough in understanding the etiology of depression. Ketamine was originally used as an anesthetic drug and later its use was extended to other therapeutic applications suc
Externí odkaz:
https://doaj.org/article/bd5956fe57ab46d5b4f96f4fdd337dd3
Autor:
Ezio Carboni, Alessandra Silvagni
Publikováno v:
Neural Plasticity, Vol 11, Iss 1-2, Pp 77-95 (2004)
The aim of this review is to compare the experimental evidence obtained from in vitro studies on the effect of amphetamine and methylphenidate on dopamine transmission with the results obtained in animal models of attention deficit hyperactivity diso
Externí odkaz:
https://doaj.org/article/6ba989d8487145bc97af716912b3b6d9
Autor:
Lucia A Ruocco, Concetta Treno, Ugo A Gironi Carnevale, Claudio Arra, Gianpiero Boatto, Maria Nieddu, Cristina Pagano, Placido Illiano, Fabiana Barbato, Angela Tino, Ezio Carboni, Giovanni Laviola, Enza Lacivita, Marcello Leopoldo, Walter Adriani, Adolfo G Sadile
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e83003 (2014)
The cross-talk at the prefronto-striatal interface involves excitatory amino acids, different receptors, transducers and modulators. We investigated long-term effects of a prepuberal, subchronic 5-HT7-R agonist (LP-211) on adult behaviour, amino acid
Externí odkaz:
https://doaj.org/article/59daa6c3beb54a9490f5dfaae9c4fc34
Publikováno v:
Parkinson's Disease, Vol 2011 (2011)
Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor (PPAR)-γ agonists commonly used as insulin-sensitizing drugs for the treatment of type 2 diabetes. In the last decade, PPAR-γ agonists have received increasing attention for t
Externí odkaz:
https://doaj.org/article/47b1a529b0074eeb8cb09b53d02b2b6c
Autor:
Maria Francesca Palmas, Anna Ena, Chiara Burgaletto, Maria Antonietta Casu, Giuseppina Cantarella, Ezio Carboni, Michela Etzi, Alfonso De Simone, Giuliana Fusco, Maria Cristina Cardia, Francesco Lai, Luca Picci, David Tweedie, Michael T. Scerba, Valentina Coroneo, Renato Bernardini, Nigel H. Greig, Augusta Pisanu, Anna R. Carta
Marketed drugs for Parkinson’s disease (PD) treat disease motor symptoms but are ineffective in stopping or slowing disease progression. In the quest of novel pharmacological approaches that may target disease progression, drug-repurposing provides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa5c5ea1addd7826c892ecae25fb893
Autor:
Anna R. Carta, Ezio Carboni
Publikováno v:
Journal of integrative neuroscience. 21(5)
Major depressive disorder is one of the primary causes of disability and disease worldwide. The therapy of depression is prevalently based on monoamine reuptake blockers; consequently, investigations aimed to clarify the aetiology of depression have
Autor:
Sandro Fenu, Saturnino Spiga, Nigel H. Greig, Augusta Pisanu, Ezio Carboni, Giovanna Mulas, Anna R. Carta, David Tweedie, Laura Boi, Michael T. Scerba
Publikováno v:
Movement Disorders. 34:1818-1830
BACKGROUND Thalidomide and closely related analogues are used clinically for their immunomodulatory and antiangiogenic properties mediated by the inhibition of the proinflammatory cytokine tumor necrosis factor α. Neuroinflammation and angiogenesis
Autor:
Ignazia Mocci, Elzbieta Janda, Anna R. Carta, Saturnino Spiga, Alfonso De Simone, Anna Ena, Maria Antonietta Casu, Maria Scherma, Augusta Pisanu, Ezio Carboni, Giovanna Mulas, Maria Francesca Palmas, Giuliana Fusco, Paola Fadda, Laura Boi, Valentina Satta
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 8535, p 8535 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 22
International journal of molecular sciences
21 (2020): 1–25. doi:10.3390/ijms21228535
info:cnr-pdr/source/autori:Boi L.; Pisanu A.; Palmas M.F.; Fusco G.; Carboni E.; Casu M.A.; Satta V.; Scherma M.; Janda E.; Mocci I.; Mulas G.; Ena A.; Spiga S.; Fadda P.; De Simone A.; Carta A.R./titolo:Modeling Parkinson's disease neuropathology and symptoms by intranigral inoculation of preformed human ?-synuclein oligomers/doi:10.3390%2Fijms21228535/rivista:International journal of molecular sciences (Print)/anno:2020/pagina_da:1/pagina_a:25/intervallo_pagine:1–25/volume:21
International Journal of Molecular Sciences
Volume 21
Issue 22
International journal of molecular sciences
21 (2020): 1–25. doi:10.3390/ijms21228535
info:cnr-pdr/source/autori:Boi L.; Pisanu A.; Palmas M.F.; Fusco G.; Carboni E.; Casu M.A.; Satta V.; Scherma M.; Janda E.; Mocci I.; Mulas G.; Ena A.; Spiga S.; Fadda P.; De Simone A.; Carta A.R./titolo:Modeling Parkinson's disease neuropathology and symptoms by intranigral inoculation of preformed human ?-synuclein oligomers/doi:10.3390%2Fijms21228535/rivista:International journal of molecular sciences (Print)/anno:2020/pagina_da:1/pagina_a:25/intervallo_pagine:1–25/volume:21
The accumulation of aggregated &alpha
synuclein (&alpha
Syn) is a hallmark of Parkinson&rsquo
s disease (PD). Current evidence indicates that small soluble &alpha
Syn oligomers (&alpha
SynOs) are the most toxic species among
synuclein (&alpha
Syn) is a hallmark of Parkinson&rsquo
s disease (PD). Current evidence indicates that small soluble &alpha
Syn oligomers (&alpha
SynOs) are the most toxic species among